Business

BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services

The new service will enable life sciences companies to seamlessly move hardware as well as biomaterials at the local level BOTHELL, Wash., June 9, 2022

articleBiolife Solutions, Inc.June 9, 20225/company/biolife-solutions-inc/news/biolife-solutions-deploys-scisafes-ultra-low-controlled-temperature-trailers-to
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services

About this update from Biolife Solutions, Inc.

[{"type":"text","content":"The new service will enable life sciences companies to seamlessly move hardware as well as biomaterials at the local level\nBOTHELL, Wash., June 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (\"CGT\") and broader biopharma markets, today announced that its SciSafe® biostorage services platform will now offer a fleet of refrigerated and ultra-low temperature (\"ULT\") truck trailers to manage local cold chain movements for customers' biologic materials. This fleet provides an ideal transportation solution for any biologic product movement requiring ULT storage between -20°C and -196°C without the added need for dry ice as it moves from pharmaceutical manufacturer to contract development and manufacturing company (\"CDMO\") sites and can be deployed worldwide. Running on generator power with two cooling systems, the fleet can also carry up to ten plugged in, powered, and running upright ULT freezers at a time, expanding supported temperatures to as low as -86°C with equipment to track location and trailer temperatures, in real time. The controlled temperature trailers can also transport liquid nitrogen storage freezers containing biologic materials stored at -150°C and colder.\n\n \n \n \n \n \n \n\n \nFrom day-to-day sample management to deploying clinical trial medicines that need ULT freezers to clinical sites, life sciences organizations, and particularly large pharmaceutical companies, face significant challenges when moving high value assets that have stringent storage temperature requirements. This new domestic transport service enables operational flexibility and reduced risk through the same provider SciSafe customers already trust with their sample management. Furthermore, the ability to ship older freezers to SciSafe for management and replace them in-facility with newer models supports campus sustainability and helps to lower energy costs.\n\"Our ability to move client biomaterials safely at ultra-low temperatures is highly valued by pharmaceutical and cell and gene therapy companies,\" said Mike Rice, Chairman and CEO of BioLife Solutions. \"This service also highly complements our internal use of our portfolio of cold chain products, including the evo® DV10 Smart Shipper™, Stirling Ultracold® freeze...

More updates from Biolife Solutions, Inc.